SavedAdd your journal

Journals / Trakya University Journal of Natural Sciences / 2023 / Cilt: 24 Sayı: 2

ISOLATION OF A NOVEL ANTIMICROBIAL POLYPEPTIDE FROM AN Aspergillus niger ISOLATE

Ayşe ÜSTÜN
Ayşenur YAZICI
Serkan ÖRTUCU
Pages
41–48
Publication Date
2023-10-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results indicate that the purified AMP molecule has the potential to be used in infections caused by S. aureus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study the extracellular proteins from the isolate LC3 belonging to Aspergillus were purified for new antimicrobial polypeptide (AMP) discovery and then tested for antimicrobial activity against Staphylococcus aureus (ATCC 25923) and Methicillin-resistant S. aureus (MRSA).
📊
Key Findings & Data:Antimicrobial activity was determined by the trypsin/proteinase K assay, which was polypeptide-based, and it was observed that this protein was a protein of about 11 kDa by gel overlay assay.
💡
Conclusion & Impact:The results indicate that the purified AMP molecule has the potential to be used in infections caused by S. aureus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antimicrobial polypeptide · Aspergillus niger · Gel overlay assay

Abstract

In this study the extracellular proteins from the isolate LC3 belonging to Aspergillus were purified for new antimicrobial polypeptide (AMP) discovery and then tested for antimicrobial activity against Staphylococcus aureus (ATCC 25923) and Methicillin-resistant S. aureus (MRSA). Antimicrobial activity was determined by the trypsin/proteinase K assay, which was polypeptide-based, and it was observed that this protein was a protein of about 11 kDa by gel overlay assay. The minimum inhibitory concentration of purified AMP molecule against S. aureus ATCC 25923 and MRSA was 8 µg/ml and 32 µg/ml, respectively and the AMP molecule was confirmed. ITS sequence analysis showed that isolate LC3 was identified as Aspergillus niger, using the Bioedit sequence assembly program. The sequence was deposited with the GenBank database with accession number MK332597. The results indicate that the purified AMP molecule has the potential to be used in infections caused by S. aureus.

Özet

Bu çalışmada Aspergillus'a ait izolat LC3'ün ekstrasellüler proteinleri, yeni antimikrobiyal polipeptit (AMP) keşfi için saflaştırıldı ve ardından Staphylococcus aureus (ATCC 25923) ve Metisiline dirençli S. aureus'a (MRSA) karşı antimikrobiyal aktivite açısından test edildi. Antimikrobiyal aktivitenin polipeptit kaynaklı olduğu tripsin/proteinaz K testi ile belirlendi ve bu proteinin jel overlay testi ile yaklaşık 11 kDa'lık bir protein olduğu gözlendi. Saflaştırılmış AMP molekülünün S. aureus ATCC 25923 ve MRSA'ya karşı minimum inhibisyon konsantrasyonu sırasıyla 8 µg/ml ve 32 µg/ml’dir ve AMP molekülü doğrulandı. ITS sekans analizi, LC3 izolatının Bioedit sekans birleştirme programı kullanılarak Aspergillus niger olarak tanımlandığını gösterdi, sekans, MK332597 erişim numarasıyla GenBank veri tabanına kaydedildi. Bu sonuçlar, saflaştırılmış AMP molekülünün S. aureus'un neden olduğu enfeksiyonlarda kullanılma potansiyeline sahip olduğunu göstermektedir.

🔖

Cite This Article

ÜSTÜN, A., YAZICI, A., ÖRTUCU, S. (2023). ISOLATION OF A NOVEL ANTIMICROBIAL POLYPEPTIDE FROM AN Aspergillus niger ISOLATE. Trakya University Journal of Natural Sciences, Cilt: 24 Sayı: 2, 41–48. https://ajindex.com/articles/967961

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Alanis, A.J. 2005. Resistance to Antibiotics: Are We in the Post-Antibiotic Era? Archives of Medical Research 36: 697-705.
  2. Al-Fakih, A.A. & Almaqtri, W.Q.A. 2019. Overview on antibacterial metabolites from terrestrial Aspergillus spp. Mycology 10: 191-209.
  3. Al-Shaibani, A.B.A., Al-Shakarchi, F.I. & Ameen, R.S. 2013. Extraction and Characterization of Antibacterial Compound from Aspergillus niger. Al-Nahrain Journal of Science 16: 167-174
  4. Apan, T.Z. 2004. Effects Of Magainin And Pexiganan As New Peptide Antibiotics. Turkish Bulletin of Hygiene and Experimental Biology, 61: 37-40
  5. Bachère, E., Gueguen, Y. & Gonzalez, M. 2004. Insights into the anti-microbial defense of marine invertebrates: the penaeid shrimps and the oyster Crassostrea gigas. Immunological Reviews 198: 149-168.
  6. Chen, Y-Y., Lin, S-Y. & Yeh, Y-Y. 2005. A modified protein precipitation procedure for efficient removal of albumin from serum. ELECTROPHORESIS 26: 2117-2127.
  7. Ebbensgaard, A., Mordhorst, H. & Overgaard, M.T. 2015. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria. PLOS ONE, 10: e0144611.
  8. Frieri M, Kumar K. & Boutin A. 2017. Antibiotic resistance. Journal of Infection and Public Health 10: 369-378.
  9. Galatenko, OA. & Terekhova, LP. 1990. Isolation of antibiotic-producing Actinomycetes from soil samples exposed to UV light. Antibiot Khimioter, 35:6-8 10. Gun Lee, D., Yub Shin, S. & Maeng, C-Y. 1999. Isolation and Characterization of a Novel Antifungal Peptide from Aspergillus niger. Biochemical and Biophysical Research Communications, 263: 646-651.
  10. Hancock, R.E.W. & Diamond, G. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends in Microbiology 8: 402-410.
  11. Huan, Y., Kong, Q., Mou, H. & Yi, H. 2020. Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Frontiers in Microbiology, 11: 582779.
  12. Jenssen, H., Hamill, P. & Hancock, R.E.W. 2006. Peptide Antimicrobial Agents. Clinical Microbiology Reviews 19: 491-511. h